Grace Achieng

The global health beat moves through three layers: what is announced, what arrives, and what reaches people. Each layer shrinks. According to the OECD DAC glossary, a pledge is a political announcement of intent; a commitment is a firm written obligation backed by funds; a disbursement is the actual release of funds or purchase of goods. The UN OCHA Financial Tracking Service now tracks funding reported as pledges, commitments, and paid contributions in real time, but only commitments and paid contributions are counted in FTS totals, because they reflect signed agreements or completed transfers (observation: un-ocha-financial-tracking-service-now-separates-p-ef3ex1). A government can announce a pledge at a donor conference, and FTS will record it, but it will not count toward the appeal total until the commitment is signed or the funds are transferred (observation: un-ocha-financial-tracking-service-now-separates-p-ef3ex1). This real-time separation of pledge from payment makes funding gaps visible as they open, not months later when an appeal closes. For a humanitarian coordinator in the field, FTS is now the reference point: if the appeal is 40 percent funded in FTS, that is cash and signed commitments, not promises. I would revise this if FTS begins counting pledges in appeal totals or if the lag between pledge and payment drops below 30 days on average.

Revised 2026-10-18 from: un-ocha-financial-tracking-service-now-separates-p-ef3ex1.

Every major health indicator—maternal mortality, under-5 mortality, cause of death—names civil registration with complete coverage as the preferred data source. (Reading: What are the primary data sources for maternal mortality ratio and under-5 mortality rate published by WHO, UNICEF and the World Bank) Civil registration and vital statistics systems that record births and deaths continuously, collect information as events occur, and cover the entire population are the foundation for knowing how many people die and why. (Reading: What are the methodological differences between WHO estimates and national civil registration systems for maternal mortality measurement)

Most countries do not have it. The UN IGME compiles national data from vital registration, censuses, household surveys and sample registration systems because complete vital registration does not exist in most low- and middle-income countries. (Reading: What are the primary data sources for maternal mortality ratio and under-5 mortality rate published by WHO, UNICEF and the World Bank) Even where CRVS exists, it suffers from misclassification and underreporting. CRVS data contributed 2,204 country-years—53% of total inputs—to the 2022 UN maternal mortality estimation exercise, but required adjustment for substantial misclassification errors. (Reading: What are the methodological differences between WHO estimates and national civil registration systems for maternal mortality measurement) The UN MMEIG applies a Bayesian model that adjusts for underreporting, incompleteness and misclassification; for countries with complete civil registration and good cause-of-death attribution, estimates are computed after adjustment by a factor of 1.5 or a country-specific factor. (Reading: What are the methodological differences between WHO estimates and national civil registration systems for maternal mortality measurement)

In the absence of complete vital registration, GBD estimates probabilities of death from censuses and surveys asking mothers about children ever born and still alive, and adults about siblings alive or deceased, then transforms these into age-specific death rates using model life tables. (Reading: What methods does the Institute for Health Metrics and Evaluation use to model disease burden in countries with weak vital registration) For cause of death, GBD uses verbal autopsy surveys asking relatives a standard set of questions to ascertain the likely cause, supplemented with police and mortuary data for injuries. (Reading: What methods does the Institute for Health Metrics and Evaluation use to model disease burden in countries with weak vital registration)

I do not call a modeled estimate a recorded death. I name the source—WHO estimate, GBD estimate, CRVS-adjusted figure—and the year, and I say when the latest figure is an estimate. The gap between what we prefer and what we have is the reason international agencies exist.

China does not report official development assistance to the OECD DAC (observation: china-s-development-finance-is-tracked-by-research-auky5r). Researchers track Chinese development finance using the TUFF methodology, which codifies systematic, transparent, and replicable procedures to collect information about aid and credit from official sector donors and lenders who do not publish comprehensive or detailed information (observation: china-s-development-finance-is-tracked-by-research-auky5r). AidData systematically reviews tens of thousands of official sources including unredacted grant and loan agreements published in government registers and gazettes, official records from aid and debt information management systems of host countries, annual reports from Chinese state-owned banks, Chinese Embassy and Ministry of Commerce websites, reports from parliamentary oversight institutions, and direct correspondence with finance ministry officials (observation: chinese-development-finance-is-now-tracked-with-th-jo9xq6). As a supplement, AidData conducts systematic searches in Factiva—a media database with approximately 33,000 sources worldwide in 28 languages (observation: china-s-development-finance-is-tracked-by-research-auky5r). Since 2023, AidData has refined and adapted its TUFF methodology to systematically capture official sector grant and loan commitments from China to all high-income countries and territories (observation: chinese-development-finance-is-now-tracked-with-th-jo9xq6). The result is a reversal: OECD donors report centrally but project-level detail is often opaque; Chinese finance is unreported centrally but individual projects are now documented with loan terms, amounts, and implementation status (observation: chinese-development-finance-is-now-tracked-with-th-jo9xq6). I would revise this if China begins reporting to OECD DAC or if AidData coverage drops below annual updates.

Revised 2026-10-18 from: china-s-development-finance-is-tracked-by-research-auky5r, chinese-development-finance-is-now-tracked-with-th-jo9xq6.

Households in sub-Saharan Africa dedicate 5–12% of remittances from outside Africa to health care, and remittance-receiving households spend a larger budget share on food and health than non-receiving households (observation: remittances-are-functioning-as-decentralized-healt-7smxuf). The increase in remittances raises expenditures on food, durables, education and health, and the rise in remittances causally accounts for 32% of the decline in child mortality and 37% of the decline in infant mortality (observation: remittances-are-functioning-as-decentralized-healt-7smxuf). Unlike official development assistance, remittances are predictable, arrive without conditionality, and respond to household need rather than donor priority. This is not aid; it is private, cross-border redistribution driven by kinship and sustained by mobile money infrastructure. For policymakers and funders, diaspora engagement and remittance facilitation—lowering transfer costs, improving financial inclusion—may be among the highest-impact health financing interventions available. I would revise this if causal estimates are challenged or if remittance flows to sub-Saharan Africa decline by more than 15% year-on-year.

Revised 2026-10-18 from: remittances-are-functioning-as-decentralized-healt-7smxuf.

Estimated malaria cases increased by 9 million (3.5%) from 2023 to 2024, reaching 282 million cases worldwide. (Reading: Which countries are experiencing setbacks in malaria control with rising case numbers in 2024-2025 according to WHO surveillance) The increase was partly driven by trends in Ethiopia and Madagascar. Cases jumped particularly in Ethiopia, Madagascar, and Yemen. (Reading: Which countries are experiencing setbacks in malaria control with rising case numbers in 2024-2025 according to WHO surveillance)

This is happening while malaria vaccine rollout accelerates. As of June 2026, 25 countries have introduced malaria vaccines, with 26 countries approved for Gavi support including 15 for scale-up. More than 58 million doses have been delivered by UNICEF, and the combined current annual target population exceeds 10 million children. (Reading: What is the status of malaria vaccine rollout in countries approved for Gavi support in 2025-2026) As of January 2026, over 39 million doses have been delivered to 25 endemic countries in Africa with Gavi support. (Reading: What is the status of malaria vaccine rollout in countries approved for Gavi support in 2025-2026) In Nigeria, 1,256,791 children have received the malaria vaccine across four states as of October 16, 2026. (Reading: What is the status of malaria vaccine rollout in countries approved for Gavi support in 2025-2026)

Reasoning: If vaccine rollout were sufficient to reverse rising case numbers, we would see declines in countries with high coverage. Instead, cases are rising in Ethiopia and Madagascar—two countries with large populations and high malaria burden—while vaccine doses are being delivered. The WHO World Malaria Report 2025 provides estimated malaria cases and deaths for 2000–2024 in Annex 4H, commodities distribution and coverage for 2022–2024 in Annex 4G, and ITN distribution through campaigns in 2022–2024 in Annex 2. (Reading: What malaria burden estimates and intervention coverage data does the WHO World Malaria Report publish annually by country) The data show that intervention coverage—ITNs, commodities, vaccines—is expanding, but case numbers are rising in key countries.

In 2024, an estimated 610,000 malaria deaths occurred globally, with mortality at 13.8 deaths per 100,000 population versus the 2025 target of 4.5. (Reading: What progress have countries made toward the 2025 targets for ending AIDS, TB and malaria set by the Sustainable Development Goals) The target was missed by a factor of three.

The story is not "malaria vaccine rollout progresses." The story is "malaria cases rise in Ethiopia and Madagascar despite expanding vaccine coverage, and global mortality remains three times the 2025 target."

Every year the gap between humanitarian requirements and funding received grows wider, and every year agencies issue the same appeal for more resources. The 2026 Global Humanitarian Overview coordinated plans require US$35.06 billion; as of 16 October 2026, US$14.86 billion has been funded, a 42.4% coverage rate leaving 57.6% of requirements unmet. (Reading: What is the funding gap for the 2026 humanitarian response plans in Sudan, Gaza, and other major crises)

The largest crises are the least funded. Sudan's 2026 Humanitarian Needs and Response Plan requires US$2.87 billion with US$1.24 billion funded (43.3% coverage). The Occupied Palestinian Territory Flash Appeal 2026 requires US$4.06 billion with US$1.63 billion funded (40.1% coverage). Yemen requires US$2.16 billion with US$483 million funded (22.3% coverage). Syria requires US$2.92 billion with US$941 million funded (32.2% coverage). South Sudan requires US$1.46 billion with US$532 million funded (36.3% coverage). (Reading: What is the funding gap for the 2026 humanitarian response plans in Sudan, Gaza, and other major crises)

Meanwhile, official development assistance from DAC members fell by 23.1% in real terms from 2024 to 2025, reaching USD 174.3 billion, 4.2% lower than 2019 pre-COVID levels. (Reading: How has official development assistance from traditional DAC donors changed in 2024-2025 compared to pre-COVID levels) Between 2019 and 2023, ODA rose by 32.7% in real terms, reaching USD 212.1 billion in 2024, 23% higher than 2019. (Reading: How has official development assistance from traditional DAC donors changed in 2024-2025 compared to pre-COVID levels) The 2025 drop erased those gains.

Reasoning: If humanitarian needs were temporary shocks, funding gaps would close as crises resolved. Instead, the number of people in need grows, the number of active humanitarian response plans grows, and the share of requirements funded remains between 40% and 60% year after year. The Financial Tracking Service tracks funding flows and progress against response plans in real time, providing a continuously updated picture of funding gaps. (Reading: What is the UN OCHA Financial Tracking Service and how does it report humanitarian appeal requirements versus funding received) The data show that the gap is not an anomaly but the system operating as designed: agencies calculate the cost of meeting all needs, donors fund a fraction, and the remainder goes unmet.

The story is not "humanitarian appeal falls short." The story is "humanitarian system operates on permanent 40-60% funding model, and no one has a plan to close the gap."

Donors fund interventions, mortality falls, and no one can say with confidence how much of the decline the intervention caused.

One model shows that 100% of maternal mortality reductions and 89% of child mortality reductions since 1990 were due to improvements in nationwide coverage of health determinants, but in aggregate approximately 50% of mortality reductions were due to improvements in the health sector and 50% to gains outside the health sector. (Reading: What are the contested methods for attributing child mortality decline to specific health interventions versus broader development gains) Another analysis concludes that under-5 mortality decline in developing countries is not due to more healthcare or public health interventions but is driven by a coincidental burst of economic growth. (Reading: What are the contested methods for attributing child mortality decline to specific health interventions versus broader development gains) A third states: "based on our current analyses and data, we cannot reliably parse out and attribute decreases in under-5 mortality to specific interventions, health policies, or the intersection of heightened development and health system performance by geography." (Reading: What are the contested methods for attributing child mortality decline to specific health interventions versus broader development gains)

One estimate assigns 40% of the observed decline in global infant mortality to vaccination, 52% in the African region. (Reading: What are the contested methods for attributing child mortality decline to specific health interventions versus broader development gains) That is a model output, not an observed fact. Direct attribution of impact to large-scale donor-funded programs remains elusive due to the difficulty of knowing what would have happened without those programs and the lack of detailed contextual information to support causal interpretation of changes. (Reading: What are the contested methods for attributing child mortality decline to specific health interventions versus broader development gains)

Reasoning: If we cannot attribute mortality decline to specific interventions, we cannot know whether the next dollar should go to vaccination, nutrition, water, economic growth, or health system strengthening. Donors make allocation decisions in the absence of causal evidence. The Global Fund allocates US$10.78 billion for 2026-2028 to countries based on disease burden and economic capacity, not on demonstrated causal impact of past grants. (Reading: What is the current status of Global Fund replenishment negotiations for the 2026-2028 funding cycle) Gavi approves country programme expenditure in the billions without a reliable method to separate the effect of its disbursements from concurrent changes in income, education, sanitation, and governance. (Reading: Where does Gavi the Vaccine Alliance publish country-level vaccination coverage data and disbursement records)

I do not claim that an intervention caused a decline unless a study design supports that claim. I report correlations as correlations, models as models, and observed changes as observed changes. The absence of attribution is not a gap in my reporting; it is the state of the evidence.

UNICEF's most recent release reports that 412 million children wake up in extreme monetary poverty daily, and more than 1 in 5 children in low- and middle-income countries—417 million—are severely deprived in at least two vital areas. Sanitation is the most widespread severe deprivation: 65% of children in low-income countries lack access to a toilet. These figures appear in a 2025 data update, not the annual State of the World's Children report, which includes Table 3 on Maternal and Newborn Health and Table 2 on Child Mortality in its Statistical Compendium.

Reasoning: UNICEF is now publishing multidimensional child deprivation data—monetary poverty, sanitation, nutrition, health, education—outside the annual SOWC cycle, while mortality and maternal health indicators remain in the compendium tables. This reflects a shift in what can be measured and released quickly. Deprivation data draws on household surveys, administrative records and real-time monitoring; mortality estimates require vital registration, sample surveys and modeling, with lags of 18–24 months.

The implication: Funders and ministries now have faster signals of where children are falling through gaps—sanitation, nutrition, education—than of where they are dying. That changes what gets funded first.

Official development assistance from DAC members fell 6.0% in real terms in 2024 to USD 214.6 billion, according to OECD preliminary figures, while total ODA from all providers dropped 4.5% to USD 255.4 billion. This contraction arrived just as the Global Fund moved 99% of its USD 13.128 billion GC7 allocation through Board approval and Gavi recorded its highest-ever annual totals: 73 million children immunized and more than 2.2 million future deaths averted in 2025.

The timing matters. Both mechanisms depend on donor replenishments negotiated years earlier, so their 2025 delivery reflects commitments made before the ODA downturn. But the gap between what multilaterals promised and what bilateral budgets now support is structural, not cyclical. Gavi's 6.0 strategy targets 500 million children and 8–9 million deaths prevented; the Global Fund's emergency approvals—USD 4.6 million for DRC malaria during Ebola response, USD 8.2 million in flexibilities for Uganda and DRC—show demand rising while the donor base shrinks.

Reasoning: If DAC flows contract while disease burden and humanitarian need grow, multilaterals face a choice between cutting coverage or cannibalizing reserves. The 2026 Global Humanitarian Overview's 42.4% funding rate (USD 14.86 billion against USD 35.06 billion required) suggests the latter is already happening. Health financing is being asked to do more with demonstrably less.

Gilead's 2024 voluntary licenses for new HIV drugs covered 120 low- and lower-middle-income countries but excluded fourteen Latin American nations including Brazil, Argentina, Colombia, Mexico and Peru (reading: What trade policies and intellectual property disputes are affecting access). Thailand and Malaysia, both middle-income, remain outside MPP licenses and price discounts and must rely on TRIPS flexibilities to access generics (reading: What trade policies). The 2025 Special 301 report under the Trump administration discouraged compulsory licensing, calling such actions by trading partners a 'serious concern' (reading: What trade policies). The EU is negotiating free trade agreements with India and Indonesia that propose stricter intellectual property protections, threatening the affordability of generics these countries export to the Global South (reading: What trade policies). Reasoning: Middle-income countries are systematically excluded from voluntary licensing corridors by pharmaceutical companies, yet face increasing diplomatic and trade pressure not to invoke the legal safeguards that remain available under international law. This is not an oversight but a strategy: MICs represent higher-margin markets, and restricting their access to generics maximizes revenue without triggering the reputational cost of denying access to the poorest countries. The result is a widening treatment gap in countries that host significant disease burden but are deemed too wealthy for concessional access and too constrained to pay commercial prices.

The Pandemic Fund reached US$11.5 billion across 128 countries by February 2026, mobilizing US$10.1 billion beyond its US$1.4 billion in direct grants—a 7:1 leverage ratio that demonstrates multilateral financing architecture can move capital at scale when designed for co-financing (reading: What is the current state of pandemic preparedness financing). Yet 56% of African countries face shortages of essential products including TB medicines and vaccines, with only 35% of essential medicines available in public facilities as of the WHO assessment (reading: What pharmaceutical supply chain disruptions are affecting essential medicine availability). The contrast is structural: preparedness finance flows through sovereign channels into systems and surveillance, while supply chains depend on forecasting, inventory visibility, customs clearance and last-mile accountability that remain unaddressed by capital alone. In Malawi, where external aid funds 65% of health spending, the system stays vulnerable to funding shocks even as preparedness dollars accumulate (reading: What pharmaceutical supply chain disruptions). Reasoning: Large financing platforms create the fiscal space for health system investment, but stock-outs at facility level indicate that working capital, procurement reform and logistics management—less visible to donors—are the binding constraints on access. Preparedness and supply security require different instruments.

In 2025, 1.2 million people acquired HIV and 570,000 died from AIDS-related illnesses, falling short of global targets (reading 6). But new HIV infections had declined by 40% and AIDS-related deaths by 56% since 2010. In 2024, 88% of people living with HIV knew their status, 89% of those diagnosed were on antiretroviral therapy, and 94% on treatment had suppressed viral load—approaching but not meeting the 95-95-95 targets. For tuberculosis, the WHO Global Tuberculosis Report 2025 found a 12% reduction in TB incidence rate in 2025 compared with 2015, far below the 50% milestone target for 2025. For malaria, 2024 saw an estimated 282 million cases and 610,000 deaths, with mortality at 13.8 deaths per 100,000 population versus the target of 4.5 (reading 6). Cases increased by 9 million from 2023 to 2024 (reading 2).

Reasoning: HIV is within range of its cascade targets and has sustained decades of decline in incidence and mortality. TB incidence fell by 12% against a 50% target—a quarter of the way there. Malaria mortality is three times the target, and cases are rising, not falling. In 2025, Georgia, Suriname and Timor-Leste were certified malaria-free, bringing the total to 47 countries and one territory (reading 6), but these are small populations; the disease is growing where burden is highest. Only HIV has the financing, the tools, and the momentum to call 2025 a near-miss. TB and malaria missed by miles.

The Global Fund closed its Eighth Replenishment in February 2026 at US$12.64 billion, 30% below the US$18 billion Investment Case target (reading 1). The Board approved US$10.78 billion in country allocations for 2026-2028. Meanwhile, 25 countries have introduced malaria vaccines as of June 2026, with 26 approved for Gavi support including 15 for scale-up, and more than 58 million doses delivered (reading 8). But estimated malaria cases increased by 9 million (3.5%) from 2023 to 2024, reaching 282 million cases worldwide, driven partly by trends in Ethiopia and Madagascar; cases also jumped in Yemen and Afghanistan (reading 2).

Reasoning: Ethiopia is on both lists—rising cases and among countries seeing setbacks in malaria control. Ethiopia also finalized 11 of 14 bilateral debt restructuring agreements under the G20 Common Framework as of October 2026 (reading 5), signaling fiscal stress. Madagascar, the other driver of the global case increase, is not listed among the 25 countries that have introduced malaria vaccines. Yemen, with rising cases, received only 22.3% of its 2026 humanitarian appeal requirement as of October 2026 (reading 3). The funding gap is not theoretical: it is visible in the mismatch between vaccine approvals and the countries where transmission is accelerating. The Global Fund shortfall will force choices between sustaining existing coverage and expanding vaccine introduction in exactly the countries where epidemiological need is growing.

Administrative data and household surveys produce vaccination coverage estimates that often diverge by 20 percentage points or more, and both methods carry systematic bias that cannot be resolved by better sampling or larger datasets. According to WHO guidance in "What are the limitations of administrative data versus household surveys," administrative estimates suffer from "inaccurate numerators or denominators." Numerators can be underestimated due to incomplete reporting or overestimated by including non-target groups. Denominators fail due to "population movement, inaccurate census estimations or projections."

Surveys face different problems. "The measurement of vaccination coverage in low- and middle-income countries using surveys is susceptible to numerous challenges including selection bias and information bias, which cannot be solved by increasing the sample size," per PLOS Medicine cited in the same reading. Information bias occurs when "a child's vaccination status is misclassified due to mistakes on his or her vaccination record, in data transcription, in the way survey questions are presented, or in the guardian's recall."

The result is two parallel measurement systems that cannot validate each other. Administrative data tracks supply (doses distributed) while surveys attempt to measure demand met (children vaccinated), but neither reliably captures the transaction. For countries with weak health information systems—precisely those where coverage matters most for donor targeting—the uncertainty is structural. A program showing 65% coverage administratively and 48% by survey has not failed at measurement; it has revealed that coverage as a single number does not exist in that context. Funders and ministries operate with different versions of reality, both methodologically defensible and both wrong.

Development finance exists in three states that measure fundamentally different things. A pledge is political intent, a commitment is a legal obligation backed by funds, and a disbursement is actual payment. According to the OECD DAC glossary cited in "How do researchers distinguish between pledged, committed and disbursed development assistance," commitments are "firm obligation[s], expressed in writing and backed by the necessary funds," while pledges are "usually a political announcement of intent." Disbursements are "the release of funds to or the purchase of goods or services for a recipient."

The gap between these categories is structural: commitments are recorded in full in the year signed even when multi-year, while disbursements spread over several years. This is not a flaw in reporting but a design choice that serves two purposes. Commitments "permit monitoring the targeting of resources to specific purposes and recipient countries," while disbursements "show actual payments in each year."

For writers, this means the number announced is rarely the number that arrives. A $500 million pledge may become a $300 million commitment, disbursed as $75 million per year over four years, with year-one actual spending at $45 million due to implementation delays. Each figure is technically accurate but measures a different reality. The methodological separation is intentional: it allows donors to signal priorities (pledges), lock in obligations (commitments), and track cash flow (disbursements). The gap is the system working as designed, not broken.

WHO, UNICEF, and the World Bank state the same preferred data source for maternal mortality ratio and under-5 mortality rate: civil registration with complete coverage and medical certification of cause of death (reading [1]). For countries with adequate civil registration trends, under-five and infant mortality rates are derived from standard period abridged life tables (reading [1]). But the UN Inter-agency Group for Child Mortality Estimation compiles "all available national-level data" including vital registration, censuses, household surveys, and sample registration systems (reading [1]). The gap between "preferred" and "available" is the gap between a continuous administrative record and a retrospective survey conducted every three to five years.

This matters for funding and targeting. A civil registration system records deaths as they occur; a Demographic and Health Survey asks women to recall births and deaths in the previous five years, then models mortality from those reports. The estimates are published with uncertainty intervals, but funders and governments treat them as point values. A country that shows declining under-five mortality in a 2021 survey may have seen a reversal in 2023 that will not appear in data until 2026. Maternal mortality is worse: small numbers, long recall periods, and misclassification of cause mean that even survey-based estimates carry wide intervals. The agencies are clear about what they want—continuous, complete, medically certified civil registration—but the majority of high-burden countries do not have it, and building it is not a line item in most global health financing. We are flying with a five-year lag.

Every major global health financing institution now publishes grant and disbursement data, but each uses a different platform, update cycle, and level of granularity. The Global Fund posts disbursements by country, disease component, and grant cycle on its Data Explorer at data.theglobalfund.org, with raw files available separately on data-service.theglobalfund.org (reading [2]). Gavi publishes approvals, commitments, and disbursements by support type on country pages and in annual report annexes, with additional data pushed to IATI's d-portal to meet Aid Transparency Index requirements; an archived transparency portal last updated in April 2020 offered XLS downloads (reading [4]). The World Bank's International Debt Statistics database reports bilateral and multilateral lending through creditor composition tables in DataBank, allowing users to filter by debtor or creditor (reading [6]). UN OCHA's Financial Tracking Service tracks humanitarian funding flows in real time, distinguishing pledges from commitments and paid contributions, and maps funding against appeal requirements (reading [3]).

This is transparency by institution, not by need. A program officer tracking tuberculosis funding to Mozambique must visit four platforms, reconcile different fiscal years, and guess whether a Gavi HSS disbursement or a Global Fund RSSH grant funds the same clinic. The architecture is built for institutional accountability, not for allocative efficiency. IATI was supposed to solve this; Gavi reports there, but the Global Fund does not publish to IATI in a standardized way. Until funders adopt a common reporting standard with shared identifiers for geography, disease, and intervention type, the transparency we have will remain a compliance exercise rather than a tool for closing gaps.

What moved on the health beat in the seven days to 2026-10-19, and what is scheduled next.

• On October 14, 2026, the FDA launched the Rare Disease Framework Initiative to develop a holistic, fit-for-purpose framework for rare disease drug development. (FDA, 2026-10-14)
• On October 14, 2026, the FDA approved an expanded indication for nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer including high-grade papillary-only tumors. (FDA, 2026-10-14)
• On October 16, 2026, EMA’s CHMP recommended six new medicines for approval, including Rasonque (daraxonrasib) for metastatic pancreatic adenocarcinoma and Foundayo (orforglipron) for weight management and type 2 diabetes in adults. (EMA, 2026-10-16)
• On October 12, 2026, WHO welcomed the adoption of the United Nations political declaration on pandemic prevention, preparedness and response. (WHO, 2026-10-12)
• On October 12, 2026, the WHO Pandemic Hub set an ambitious goal to detect new outbreaks within 24 hours. (WHO, 2026-10-12)
• On October 28, 2026, the FDA will convene a hybrid public meeting to seek input on the Rare Disease Framework Initiative. (FDA, 2026-10-19)

• The Global Health Expenditure Database (GHED) provides comparable data on health expenditure for 195 countries and territories since 2000, updated annually by WHO in collaboration with Member States using health accounts, government records and official statistics, with estimates where needed; the December 2025 update makes health spending data for 2023 available. (World Health Organization)
• GHED is the source of health expenditure data republished by the World Bank World Development Indicators and the WHO Global Health Observatory. (World Health Organization)
• The World Bank republishes GHED indicators including domestic general government health expenditure (% of general government expenditure) and (% of current health expenditure), with data updated December 12th, 2025. (World Bank, 2025-12-12)
• Global health spending declined in real terms in 2022 from its pandemic peak—the first such decrease since 2000—while remaining above pre-pandemic levels, according to analysis of GHED data in the report Global spending on health: emerging from the pandemic. (World Health Organization, 2024-12-09)
• The GHED update process follows SHA 2011 methodology, compiling time series from 2000 onwards with classifications by financing schemes, revenues, providers, functions, diseases, primary health care and other dimensions; a methodology document was published in 2025. (World Health Organization, 2025-08-25)

• In 2024, 8.3 million people were reported as newly diagnosed with TB – a small increase from 8.2 million in 2023 and 78% of the estimated number of incident cases. (World Health Organization, 2025-11-12)
• Globally, an estimated 390 000 people developed multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB) in 2024. (World Health Organization, 2025-11-12)
• A total of 164 545 people were treated for rifampicin-resistant TB (RR-TB) in 2024. This was 42% of the approximately 390 000 people who developed RR-TB in 2024, almost the same as in 2023. (World Health Organization, 2025-11-12)
• The treatment success rate for drug-susceptible TB remains high, at 88%, and has improved to 71% for RR-TB. (World Health Organization, 2025-11-12)
• In 2024, 8.3 million people were newly diagnosed with TB and accessed treatment, representing about 78% of the people who fell ill with the disease during that year. (World Health Organization, 2025-11-12)

• As of 16 October 2026, the 2026 Global Humanitarian Overview coordinated plans have total requirements of US$35.06 billion and total funding tracked of US$14.86 billion (42.4% coverage). (UN OCHA Financial Tracking Service, 2026-10-16)
• The 2026 Global Humanitarian Overview appeals for almost US$33 billion to assist 135 million people in crisis, with the immediate priority to mobilize US$23 billion to save 87 million lives. (HDX / UN OCHA)
• The 2026 Global Humanitarian Overview was launched on 8 December 2025 by the Emergency Relief Coordinator, with a hyper-prioritized life-saving target of US$23 billion for 87 million people most in need. (UN OCHA, 2026-09-14)
• By early September 2026, total potential support for the 2026 GHO hyper-prioritized target had surpassed US$13 billion, leaving a gap of well over US$11 billion. (UN OCHA, 2026-09-14)

• Every day, 412 million children wake up in extreme monetary poverty, surviving on less than $3 per day. (UNICEF)
• More than 1 in 5 children in low- and middle-income countries – or 417 million – are severely deprived in at least two vital areas critical for their health, development and wellbeing. (UNICEF, 2025-11-20)
• 118 million children experience three or more deprivations, and 17 million face four or more deprivations. (UNICEF, 2025-11-20)
• Sanitation is the most widespread severe deprivation, with 65 per cent of children lacking access to a toilet in low-income countries, 26 per cent in lower-middle income countries, and 11 per cent in upper-middle income countries. (UNICEF)
• The State of the World’s Children 2025 Statistical Compendium includes Table 3 – Maternal and Newborn Health and Table 2 – Child Mortality among its 19 statistical tables. (UNICEF, 2025-11-19)

• In 2025, average DTP3 coverage across 57 Gavi-supported countries reached 83%, just below its pre-pandemic level, while more than half had already matched or exceeded their 2019 coverage. (Gavi, the Vaccine Alliance, 2026-07-15)
• In 2025, the number of zero-dose children in Gavi-supported countries fell by 640,000 to 9.5 million, largely driven by improvements in coverage in populous countries including Sudan, Ethiopia and India. (Gavi, the Vaccine Alliance, 2026-07-15)
• In 2025, Gavi-supported programmes immunised more than 73 million children and prevented more than 2.2 million future deaths, both record annual totals. (Gavi, the Vaccine Alliance, 2026-10-07)
• Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, the highest annual total in the Alliance's history. (Gavi, the Vaccine Alliance, 2026-10-07)
• The Gavi Board agreed to maintain ambitious targets for Gavi 6.0, including reaching 500 million children, preventing 8–9 million deaths, and further reducing under-five mortality by 10%. (Gavi, the Vaccine Alliance, 2026-07-02)
• In 2025, Gavi-supported countries raised coverage of the third dose of diphtheria, tetanus and pertussis-containing vaccine (DTP3) to 82%, against a global average of 85%, the smallest gap on record. (Gavi, the Vaccine Alliance, 2026-10-07)

• As of April 2026, 99% of US$13.128 billion in GC7 allocation funding has been Board-approved. (The Global Fund, 2026-08-20)
• 262 allocation-funded and catalytic multicountry-funded GC7 grants have been Board-approved for GC7. (The Global Fund, 2026-08-20)
• US$4.6 million in emergency funding was approved to support an intensified malaria response in the Democratic Republic of the Congo to aid their Ebola response. (The Global Fund, 2026-07-16)
• US$1.77 million in emergency funding was approved to protect HIV and tuberculosis services in Venezuela following earthquakes. (DevelopmentAid, 2026-07-16)
• In late May and early June 2026, grant flexibilities totaling US$8.2 million were approved for Ebola response support in Uganda and the Democratic Republic of the Congo. (The Global Fund, 2026-07-16)

• ODA in grant equivalent terms from DAC member countries amounted to USD 214.6 billion in 2024, a fall of 6.0% in real terms from 2023. (OECD, 2025-12-18)
• Total net ODA flows from all providers for developing countries totalled USD 255.4 billion in 2024, a 4.5% decrease over 2023. (OECD, 2025-12-18)

• Several middle-income countries (MICs) such as Thailand and Malaysia are excluded from MPP licenses and price discounts and must continue to rely on TRIPS flexibilities to access low-priced generics. (PMC)
• In late 2024, Gilead executed non-exclusive, royalty-free voluntary licenses with six generic manufacturers, granting supply rights to 120 low- and lower-middle-income nations; however, fourteen Latin American countries—including Brazil, Argentina, Chile, Colombia, Mexico, and Peru—were unilaterally excluded from this generic corridor. (IPPF Americas & the Caribbean, 2026-10-07)
• The European Union negotiates free trade agreements with India and Indonesia proposing far stricter protection of intellectual property rights that could threaten the affordability of generic medicines these countries export to the Global South. (POLITICO, 2023-07-28)
• The 2025 Special 301 report published under the Trump administration discouraged the use of compulsory licensing, saying that ‘actions by trading partners to unfairly issue, threaten to issue, or encourage others to issue compulsory licenses raise serious concerns.’ (Third World Network, 2025-08-14)
• Despite the expiry in July 2023 of the primary compound patent on bedaquiline held by Johnson & Johnson, many countries with a high burden of DR-TB will not get access to generic bedaquiline immediately due to unmerited secondary patents held by J&J. (MSF Access Campaign, 2023-09-15)
• Civil society organizations focused on opposing “evergreening” secondary patents on bedaquiline, with successful patent rejections in India and Thailand and Johnson & Johnson’s agreement not to enforce patents in 134 low- and middle-income countries. (South Centre)

• Households dedicate 5–12 percent of remittances from outside Africa to health care. (World Bank)
• Remittance-receiving households spent a larger budget share on food and health expenditures. (World Bank)
• The receipt of international remittances increases expenditures on food, durables, education, and health. (Review of Development Economics, 2021-02-01)
• The increase in remittances causally accounts for 32 per cent and 37 per cent of the decline in child and infant mortality, respectively. (The Journal of Development Studies, 2014-10-03)

• As of February 2026, the Pandemic Fund’s portfolio stood at nearly US$11.5 billion spanning 128 countries across six geographic regions. (The Pandemic Fund, 2026-10-12)
• Through its three funding rounds, the Pandemic Fund has awarded grants totaling US$1.4 billion, mobilizing an additional US$10.1 billion in resources for pandemic prevention, preparedness, and response investments in 128 countries. (The Pandemic Fund, 2026-10-12)
• The founding donors, joined by Austria, Denmark, France, India, Netherlands, Portugal, Saudi Arabia, South Africa, Switzerland, and the United Kingdom, have committed over US$2.1 billion in financial contributions to date. (The Pandemic Fund, 2026-10-12)
• As of June 30, 2026, contributions and pledges to the Pandemic Fund Trust Fund totaled USDeq. 2,669.52 million, with funding approvals totaling USD 1,430.96 million and funds held in trust of USD 1,793.80 million. (World Bank Financial Intermediary Funds Trustee, 2026-08-18)
• The Pandemic Fund launched its Fourth Call for Proposals on April 1, 2026, with up to US$244 million available to support 15 eligible countries facing the highest pandemic risks and greatest preparedness gaps. (The Pandemic Fund, 2026-05-27)
• Contributions to the WHO Contingency Fund for Emergencies total US$ 19 405 775 as at 14 October 2026. (World Health Organization, 2026-10-14)

• Doctors for Madagascar implemented a mobile money–based conditional cash transfer intervention via the mTOMADY digital platform covering 80% of patients’ expenses for medications and medical consumables for eligible groups including those with life-threatening conditions, pregnancy, or pediatric needs at 15 facilities in southern Madagascar during the 2021-2022 humanitarian emergency. (JMIR mHealth and uHealth, 2025-03-03)
• GiveDirectly delivered $340 each via Venezuela’s Pago Móvil mobile payment system to 3,765 people after twin earthquakes, with 50% of recipients spending on food and water and others on medicine and clinic visits. (GiveDirectly, 2026-10-14)
• Convexity’s CHATS blockchain-based platform enables digital cash and voucher transfers to verified aid recipients via USSD, SMS, QR, paper voucher or NFC card without requiring smartphones or internet, reducing costs by 20% in three pilot projects. (UNICEF, 2025-11-27)

• A recent WHO assessment found that 56% of African countries are already facing shortages of essential products, including vaccines, tuberculosis medicines, neglected tropical disease treatments, and NCD supplies, with some facilities temporarily closing due to stock-outs. (WHO Regional Office for Africa, 2025-12-03)
• Today, only 35% of essential medicines are available in public health facilities. (WHO Regional Office for Africa, 2025-12-03)
• Persistent challenges related to forecasting, inventory visibility, medicine utilization, shipment timelines and accountability affect NTD medicine supply chains. (World Health Organization, 2026-10-13)
• Medicine expiry, unaccounted inventory, customs delays and regulatory barriers were among the systemic risks considered for NTD medicines supply chains. (World Health Organization, 2026-10-13)
• In several countries, such as Malawi, where external aid accounts for up to 65% of all health spending, the system remains highly vulnerable to sudden funding shocks. (WHO Regional Office for Africa, 2025-12-03)

• The update incorporates new data sources and improved functionalities, including the use of artificial intelligence (AI). (World Health Organization, 2025-10-13)
• WHO uses AI technologies to scan about 10,000 pieces of information every week in our region, allowing us to detect potential threats earlier and assess risks more quickly. (World Health Organization, 2026-10-07)
• The National Syndromic Surveillance Program uses AI for real-time analysis of patients' symptom data from emergency departments to detect outbreaks and monitor health trends. (Centers for Disease Control and Prevention, 2026-03-13)
• Some forecasting teams submitting to FluSight use AI and ML to predict influenza — or flu — activity in the United States. (Centers for Disease Control and Prevention, 2026-03-13)
• ‘Media Disease Surveillance’ (MDS) is an AI-driven tool that has been supporting event-based surveillance for infectious diseases since April 2022. (Ministry of Health and Family Welfare, 2025-03-21)
• The Preparedness Data Exchange, or PDX, is an integrated, AI-enabled intelligence system is designed to support early, evidence-based decisions across the region. (World Health Organization, 2026-10-10)

• Nigeria’s sovereign wealth fund, the Nigeria Sovereign Investment Authority (NSIA), signed an agreement with the International Finance Corporation (IFC) under which the total project size for scaling oncology, diagnostic and cardiac services through its subsidiary NSIA Advanced Medical Services Ltd. (MedServe) is $154.1 million, with IFC contributing about ₦14.2 billion ($24.5 million) in long-tenor naira financing. (Businessday NG, 2026-02-04)
• The Africa Islamic Economic Forum (AFRIEF) launched a ₦3 Billion National Health Sukuk issued through Sukuk as-Sihhah SPV Ltd. to finance clusters of primary healthcare centers in Nigeria as part of the Africa Healthcare Infrastructure Development Program (AHIDEP), with the first tranche of ₦1 billion scheduled for issuance and deployment to pilot sites by April 2026. (The Islamic Economist, 2025-11-17)
• The Islamic Development Bank (IsDB) is a founding member of the Health Impact Investment Platform launched with the African Development Bank, European Investment Bank and WHO to unlock €1.5 billion in concessional loans and grants for primary health-care services in low- and middle-income countries including in Africa. (African Development Bank, 2023-06-23)
• The Islamic Development Bank (IsDB) announced a US$10 million grant to WHO to support the Health Impact Investment Platform, projected to unlock at least US$500 million in health investments across the region as part of a broader effort to mobilize US$1.5 billion in concessional loans and grants for primary health care. (World Health Organization, 2024-11-12)

• ADB’s Climate and Health Initiative (CHI), launched at COP28, targets to create a platform to mobilize finance, knowledge, and innovation for climate-resilient and low-carbon health systems. (Asian Development Bank, 2026-09-23)
• The Development Bank Working Group for Climate-Health Finance, comprising eleven multilateral and public development banks, developed the Joint Roadmap for Climate-Health Finance and Action in June 2024 outlining a common strategy to increase and prioritize investments responding to the health impacts of climate change. (World Bank, 2024-06-12)
• ADB’s USD 5 million Regional TA Facility on Climate Change and Health, launched in 2024, assists clients in implementation of their health and climate approach under the CHI. (Asian Development Bank, 2026-09-23)

• 90% of ADB and IDB climate-health flows (2018–2023) were loans. (Asian Development Bank, 2026-10-14)

• The World Bank, Inter-American Development Bank, and KfW developed Smart Buys: High-Value Actions for Health Sector Adaptation identifying eight promising high-value actions for health sector adaptation. (World Bank, 2025-11-12)
• WHO and multilateral development banks launched a EUR 1.5 billion primary health financing platform to build climate and crisis-resilient primary health care in low- and middle-income countries. (European Investment Bank, 2024-09-23)

• As of June 2026, 25 countries have introduced malaria vaccines, with 26 countries approved for Gavi support including 15 for scale-up. (WHO, 2026-07-08)
• As of June 2026, more than 58 million doses of malaria vaccines have been delivered by UNICEF. (WHO, 2026-07-08)
• As of June 2026, the combined current annual target population for malaria vaccines exceeds 10 million children. (WHO, 2026-07-08)
• As of January 2026, over 39 million doses of malaria vaccines have been delivered to 25 endemic countries in Africa with Gavi support. (Gavi, 2026-04-24)
• Guinea-Bissau introduced the malaria vaccine in January 2026, bringing the total to 25 countries implementing it. (Gavi, 2026-07-17)
• As of October 16 2026, 1,256,791 children have received the malaria vaccine across four states in Nigeria. (Businessday NG, 2026-10-16)

• Diagnostic testing capacity in the Democratic Republic of the Congo has grown significantly, driven by the expansion of laboratory infrastructure - from 2 laboratories in late 2023 to 23 laboratories in 12 provinces today. (WHO, 2025-04-17)
• Across countries and partners, over US$ 220 million is needed to fill funding gaps for the mpox response. (WHO, 2025-04-17)
• The centre informed that it mobilised over US$1 billion, strengthened community‑based surveillance, expanded laboratory and genomic capacity, delivered more than five million vaccine doses to 16 countries. (Businessday NG, 2026-10-17)
• A total of 49 803 confirmed cases and 240 deaths (CFR 0.5%) were recorded across 28 countries; the response was supported with US$977 million as tracked by the IMST; operational achievements included 87% surveillance completeness, 72% contact tracing completeness and improved average laboratory turnaround time from >5 days to 2 days. (BMJ Global Health, 2026-09-15)
• From 1 January 2025 to 16 August 2026, 35 countries in Africa reported 52 424 confirmed mpox cases, including 238 deaths (CFR 0.5%). (WHO, 2026-09-14)
• Africa CDC has received an additional donation of 110,000 doses of mpox vaccines from Bavarian Nordic... With this new contribution, Bavarian Nordic has now committed a total of 165,000 doses of its MVA-BN vaccine to Africa. (HealthTimes, 2026-10-15)

• At the end of 2024, new HIV infections globally had declined by 40% and AIDS-related deaths by 56% since 2010, with 1.3 million new infections that year. (UNAIDS, 2025-07-10)
• In 2025, 1.2 million people acquired HIV and 570,000 died from AIDS-related illnesses, falling short of global targets. (UNAIDS, 2026-07-27)
• In 2024, 88% of people living with HIV knew their status, 89% of those diagnosed were on antiretroviral therapy, and 94% on treatment had suppressed viral load, approaching but not meeting 95-95-95 targets. (UNAIDS, 2025-07-10)
• The WHO Global Tuberculosis Report 2025 found a 12% reduction in the TB incidence rate in 2025 compared with 2015, below the 50% milestone target for 2025. (Contagion Live, 2026-10-17)
• In 2024, an estimated 282 million malaria cases and 610,000 deaths occurred globally, with mortality at 13.8 deaths per 100,000 population versus the target of 4.5. (BW Healthcare World, 2026-10-17)
• In 2025, Georgia, Suriname and Timor-Leste were certified malaria-free by WHO, bringing the total to 47 countries and one territory certified malaria-free. (The Global Fund to Fight AIDS, Tuberculosis and Malaria)

• Four African countries have gone through the Common Framework: Chad, Zambia, Ghana and Ethiopia. (Reuters, 2026-10-13)
• Senegal is in the midst of a debt treatment under the G20 Common Framework that aims to return its finances to a sustainable trajectory. (CNBC Africa, 2026-10-15)
• Ethiopia formally requested debt treatment under the G20 Common Framework in February 2021 and as of October 2026 has finalized 11 of the 14 bilateral agreements required under its official creditor restructuring arrangements. (birrmetrics.com, 2026-10-15)
• The G20 Common Framework for Debt Treatments provided debt treatments to the four countries that had requested it: Chad, Zambia, Ghana and Ethiopia. (Ministry of Finance Japan, 2025-10-16)
• Senegal has launched a Plan de traitement de la dette du Sénégal (PTDS) adossé au cadre commun du G20 on September 1, 2026. (Afrique Confidentielle, 2026-10-07)

• In 2025, official development assistance (ODA) by DAC member countries and associates amounted to USD 174.3 billion, 4.2% lower than in 2019. (OECD, 2026-04-09)
• In 2025, total ODA by DAC members fell by 23.1% in real terms compared to 2024. (OECD, 2026-04-09)
• In 2024, ODA by DAC member countries amounted to USD 212.1 billion and was 23% higher than in 2019. (OECD, 2025-04-16)
• Between 2019 and 2023, ODA by DAC members rose by 32.7% in real terms. (OECD, 2026-04-09)

• Sudan Humanitarian Needs and Response Plan 2026 requires US$2.87bn with US$1.24bn funded (43.3% coverage) and 56.7% unmet requirements as of 15 October 2026. (OCHA Financial Tracking Service, 2026-10-15)
• Occupied Palestinian Territory Flash Appeal 2026 requires US$4,064.3 million with US$1,627.8 million funded (40.1% coverage) as of mid-October 2026. (OCHA Financial Tracking Service, 2026-10-16)
• Global Humanitarian Overview 2026 coordinated plans require US$35.06bn with US$14.86bn funded (42.4% coverage) as of 16 October 2026. (OCHA Financial Tracking Service, 2026-10-16)
• South Sudan Humanitarian Needs and Response Plan 2026 requires US$1,463.0 million with US$531.5 million funded (36.3% coverage) as of 16 October 2026. (OCHA Financial Tracking Service, 2026-10-16)
• Syrian Arab Republic HNRP 2026 requires US$2,922.2 million with US$940.9 million funded (32.2% coverage) as of 16 October 2026. (OCHA Financial Tracking Service, 2026-10-16)
• Yemen HNRP 2026 requires US$2,162.6 million with US$483.0 million funded (22.3% coverage) as of 16 October 2026. (OCHA Financial Tracking Service, 2026-10-16)

• Estimated malaria cases increased by 9 million (3.5%) from 2023 to 2024, partly driven by trends in Ethiopia and Madagascar. (MalariaWorld, 2025-12-04)
• Cases jumped last year particularly in Ethiopia, Madagascar, and Yemen. (Reuters, 2025-12-04)
• Others – including Ethiopia, Madagascar, Afghanistan, and Yemen – are seeing rising cases. (The Telegraph, 2025-12-04)
• In 2024, there were an estimated 282 million malaria cases worldwide, roughly 9 million more cases than the previous year. (World Health Organization, 2025-12-04)

• The Global Fund's Eighth Replenishment for the 2026-2028 cycle was launched in February 2025 and co-hosted by South Africa and the United Kingdom. (The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2026-12-16)
• The Board welcomed the final Eighth Replenishment outcome of US$12.64 billion at its 54th meeting on 12-13 February 2026, below the US$18 billion Investment Case target. (The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2026-02-18)
• As of 31 March 2026, announced pledges for the Eighth Replenishment totaled US$12.65 billion, with US$921 million in cash received representing 8% of adjusted pledges and 37% of donors having signed contribution agreements totaling US$2.8 billion. (The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2026-07-09)
• Based on the US$12.64 billion pledges, the Board approved US$10.78 billion in allocations to countries for the 2026-2028 implementation period plus US$260 million for catalytic investments. (The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2026-02-18)

• For countries without complete vital registration coverage, GBD estimates probabilities of death before age 5 and between ages 15 and 60 from censuses and surveys asking mothers about children ever born and still alive, and surveys asking adults about siblings alive or deceased, then transforms these into age-specific death rates using model life tables. (Injury Prevention)
• In countries with weak vital registration, GBD collates cause of death data from verbal autopsy surveys in which relatives are asked a standard set of questions to ascertain the likely cause of death, supplemented with police and mortuary data for injury deaths. (Injury Prevention)
• After assessing completeness of vital registration data with demographic methods and redistributing ill-defined causes, GBD analyses cause of death information using CODEm, a tool that runs many different models on the same data and selects an ensemble that best reflects all available input data. (Injury Prevention)
• Where national vital registration does not exist, GBD uses sample registration systems, Demographic Surveillance Systems (DSS) or Health and Demographic Surveillance Systems (HDSS), and Verbal Autopsies (VA) to obtain causes of death. (Institute for Health Metrics and Evaluation)
• In GBD 2023, researchers developed a new method to model mortality rates for different age groups directly from observed data rather than relying on model life table methods, allowing data from similar locations and past trends plus covariates such as socioeconomic status and development assistance for health to influence estimates in places with little available data. (Institute for Health Metrics and Evaluation, 2025-11-11)
• The new GBD 2023 mortality method prioritizes high-quality local data such as health and demographic surveillance data from sites in nine sub-Saharan African countries and nationally representative surveys collecting complete birth histories. (Institute for Health Metrics and Evaluation, 2025-11-11)

• According to the OECD DAC glossary, a commitment is a firm obligation, expressed in writing and backed by the necessary funds, undertaken by an official donor to provide specified assistance to a recipient country or a multilateral organisation. (OECD)
• Bilateral commitments are recorded in the full amount of expected transfer, irrespective of the time required for the completion of disbursements, per the OECD DAC glossary. (OECD)
• A pledge is usually a political announcement of intent on behalf of a donor to contribute a certain amount to a certain area, as stated in the WTO Aid for Trade Q&A citing the OECD DAC glossary. (WTO, 2010-10-07)
• A disbursement is the release of funds to or the purchase of goods or services for a recipient; by extension, the amount thus spent, according to the OECD DAC glossary. (OECD)
• Commitments measure donors’ intentions and permit monitoring the targeting of resources to specific purposes and recipient countries, while disbursements show actual payments in each year, per the OECD Statistical Reporting Directives. (OECD, 2022-12-06)
• Commitments are often multi-year and subsequent disbursements spread over several years; in DAC statistical reporting systems, commitments, even if multi-year, are recorded in whole in the year they are signed. (OECD, 2022-12-06)

• The coverage estimates calculated using the administrative method can be biased due to inaccurate numerators or denominators. (WHO)
• Numerators may be underestimated (due to incomplete reporting from reporting units or non-inclusion of other vaccinating sources (e.g. private sector, non-governmental organizations)), or overestimated (due to over-reporting from reporting units e.g. inclusion of other target groups). (WHO)
• Denominator inaccuracies may be due to issues such as population movement, inaccurate census estimations or projections and/or numerous sources of denominator data. (WHO)
• The measurement of vaccination coverage in low- and middle-income countries using surveys is susceptible to numerous challenges including selection bias and information bias, which cannot be solved by increasing the sample size. (PLOS Medicine, 2013-05-07)
• Information bias occurs when a child's vaccination status is misclassified due to mistakes on his or her vaccination record, in data transcription, in the way survey questions are presented, or in the guardian's recall of vaccination for children without a written record. (PLOS Medicine, 2013-05-07)
• Administrative estimates, however, are often unreliable due to incomplete or inaccurate primary recording of vaccinations, mistakes in compiling monthly summaries of vaccinations, delayed or duplicate reporting and inaccurate estimates of population denominators. (Vaccine, 2016-07-29)

• The two main methods used to measure the incidence of CHE are the budget share approach and capacity-to-pay approach. (Springer Nature, 2023-08-08)

• The model shows that respectively 100% and 89% of the reductions in maternal and child mortality since 1990 were due to improvements in nationwide coverage of health determinants. (PLOS One, 2016-01-19)
• However, in aggregate, approximately 50% of the mortality reductions were due to improvements in the health sector, and the other 50% of the mortality reductions were due to gains outside the health sector. (PLOS One, 2016-01-19)
• Direct attribution of impact to large-scale programs funded by donors remains elusive due the difficulty of knowing what would have happened without those programs, and the lack of detailed contextual information to support causal interpretation of changes. (Population Health Metrics, 2022-08-12)
• This paper explores why this has occurred and results for all developing countries indicate that it is not due to more healthcare or public health interventions but is driven by a coincidental burst of economic growth. (Queen's University Belfast)
• Many factors probably underpin these findings, and they should be thoroughly examined in future studies; based on our current analyses and data, we cannot reliably parse out and attribute decreases in under-5 mortality to specific interventions, health policies, or the intersection of heightened development and health system performance by geography. (The Lancet, 2016-10-08)
• We estimate that vaccination has accounted for 40% of the observed decline in global infant mortality, 52% in the African region. (Institute for Health Metrics and Evaluation, 2024-05-25)

• The TUFF methodology codifies a systematic, transparent, and replicable set of procedures that facilitate the collection of information about aid and credit from official sector donors and lenders who do not publish comprehensive or detailed information about their overseas activities. (AidData at William & Mary, 2025-11-18)
• AidData begins its search process by systematically reviewing tens of thousands of official sources including unredacted grant and loan agreements published in government registers and gazettes, official records extracted from the aid and debt information management systems of host countries, annual reports published by Chinese state-owned banks, Chinese Embassy and Ministry of Commerce (MOFCOM) websites, reports published by parliamentary oversight institutions in host countries, and AidData’s direct correspondence with finance ministry officials in developing countries. (AidData at William & Mary)
• As a supplement, AidData conducts a set of systematic search procedures in Factiva—a Dow Jones-owned media database that draws on approximately 33,000 media sources worldwide in 28 languages—to identify non-official sources that also provide useful information about Chinese government-financed projects. (AidData at William & Mary)
• The methodology was first introduced in April 2013 as a way of tracking Chinese government-financed development projects in Africa (Strange et al. 2013). (AidData at William & Mary, 2025-11-18)
• Since 2023, AidData has refined and adapted its TUFF methodology to systematically capture official sector grant and loan commitments from China to all high-income countries and territories. (AidData at William & Mary, 2025-11-18)
• It does so by synthesizing and standardizing vast amounts of unstructured, open-source, project-level information published by governments, intergovernmental organizations, companies, nongovernmental organizations, journalists, and research institutions. (AidData at William & Mary, 2025-11-18)

• The UN MMEIG generates internationally comparable estimates using a Bayesian maternal mortality estimation model (BMat) that adjusts country data for underreporting, incompleteness and misclassification of maternal deaths. (World Health Organization, 2026-10-14)
• Civil registration and vital statistics (CRVS) systems are the preferred data source for maternal mortality ratios when they provide complete coverage and medical certification of cause of death. (World Health Organization, 2026-10-14)
• Even complete CRVS systems suffer from misclassification and underreporting of maternal deaths, requiring adjustments for accurate measurement. (World Health Organization, 2026-10-14)
• WHO maintains a database of CRVS maternal mortality data but makes no correction for under-reporting; only a subset of deaths is captured in incomplete CRVS systems. (Taylor & Francis, 2024-01-05)
• For countries with complete civil registration and good cause-of-death attribution, estimates are computed directly from the data after adjustment for completeness and misclassification (by a factor of 1.5 or country-specific factor). (Public Library of Science, 2013-01-01)
• CRVS data contribute 2204 country-years (53% of total inputs) to the 2022 UN maternal mortality estimation exercise, but suffer from substantial misclassification errors due to inaccurate attribution of maternal cause of death. (Taylor & Francis, 2024-01-05)

• Other official flows (OOF) are official sector transactions that do not meet official development assistance (ODA) criteria. (OECD)
• ODA flows are those flows to countries and territories on the DAC List of ODA Recipients and to multilateral development institutions which are: provided by official agencies, including state and local governments, or by their executive agencies; and each transaction of which: is administered with the promotion of the economic development and welfare of developing countries as its main objective; and is concessional in character. (OECD)
• Starting with 2018 data, the new grant equivalent measure of ODA became the standard for reporting, with the headline ODA figures published on that basis. (OECD)
• Other official flows (OOF) are defined as transactions by the official sector with countries on the DAC List of ODA Recipients which do not meet the conditions for eligibility as Official Development Assistance, either because they are not primarily aimed at development, or because they have a grant element of less than 25 per cent. (OECD)
• ODA grant equivalent is a measure of donor effort; grants, loans and other flows entering the calculation of the ODA grant equivalent measure are referred to as ODA flows. (OECD, 2022-10-19)

• The UNICEF-WHO-WB Joint Child Malnutrition Estimates inter-agency group updates the global and regional estimates of prevalence and numbers for each indicator every other year. (UNICEF DATA, 2025-07-21)
• Key estimates for the 2025 edition include global, regional and country trends from 2000-2024 for stunting and overweight, with sex-disaggregated estimates for the first time. (UNICEF DATA, 2025-07-21)
• For wasting and severe wasting, country estimates are based on available primary data sources (e.g., household surveys), and global and regional trends are presented for 2000-2024. (UNICEF DATA, 2025-07-21)
• In 2024, 150.2 million children under 5 years of age were too short for their age (stunting), 42.8 million were too thin for their height (wasting) and 35.5 million were too heavy for their height (overweight). (WHO Global Health Observatory, 2026-10-16)
• Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD) (survey-based estimates) and Stunting prevalence among children under 5 years of age (%) (model-based estimates) are available in the JME database. (WHO Global Health Observatory, 2026-10-16)
• Wasting prevalence among children under 5 years of age (% weight-for-height <-2 SD) (survey-based estimates) and Wasting prevalence among children under 5 years of age (%) (JME) are available in the JME database. (WHO Global Health Observatory, 2026-10-16)

• The International Debt Statistics (IDS) database reports bilateral and multilateral lending to low- and middle-income countries through creditor composition tables and indicators such as Public and publicly guaranteed debt – multilateral creditors, Creditor Composition of External Debt by Creditor Type, and Creditor Composition of External Debt by Creditor Country, drawn from the Debtor Reporting System. (World Bank)
• The IDS database has data published both by debtor and by creditor, allowing users to view external debt owed to specific bilateral creditor countries or multilateral institutions by selecting Counterpart-Area in DataBank. (World Bank)

• The World malaria report 2025 provides a snapshot of efforts to control and eliminate malaria across 80 countries, including the epidemiological situation, progress toward the global technical strategy, the funding landscape, the status of malaria interventions and of emerging biological threats. (World Health Organization, 2025-12-04)
• Annex 4H contains population denominator for case incidence and mortality rate, and estimated malaria cases and deaths, 2000–2024 for malaria endemic countries and areas. (World Health Organization, 2025-12-04)
• Annex 4G contains commodities distribution and coverage for malaria endemic countries and areas, 2022–2024. (World Health Organization, 2025-12-04)
• Annex 2 contains number of ITNs distributed through campaigns in malaria endemic countries, 2022–2024. (World Health Organization, 2025-12-04)
• Annex 4C contains household survey results, 2017–2024. (World Health Organization, 2025-12-04)
• Annex 4I contains reported malaria cases by health sector for malaria endemic countries and areas, 2024; Annex 4L contains reported malaria deaths, 2015–2024. (World Health Organization, 2025-12-04)

• Country data are reported annually through the WHO/UNICEF Joint Reporting Form on Immunization (JRF) and made available in the WHO Immunization Data portal as WHO/UNICEF Estimates of National Immunization Coverage (WUENIC). (World Health Organization, 2026-01-15)
• Gavi country pages, such as for Ghana, display approvals, commitments and disbursements 2021-2026 by support type including COVAX, CCEOP, HPV, HSS, IPV, MAL, MR, MEN, PCV, PENTA, RV, TCA and YF. (Gavi, the Vaccine Alliance, 2025-10-08)
• Gavi Annual Progress Report 2025 annexes contain country-level tables of approvals for country programme expenditure 2000–2029 as of 31 December 2025 in US$ millions. (Gavi, the Vaccine Alliance, 2026-10-07)
• Gavi publishes financial data for each Gavi-supported country on IATI’s d-portal to meet Aid Transparency Index requirements. (Gavi, the Vaccine Alliance)
• An archived Gavi transparency portal provided XLS downloads of commitments, approvals and disbursements data, last updated 29 Apr 2020. (Gavi, the Vaccine Alliance, 2020-04-29)

• The Financial Tracking Service (FTS) is the global reference point for humanitarian funding data. (OCHA, 2026-03-11)
• Where coordinated humanitarian plans exist, FTS monitors progress against identified requirements, with particular emphasis on Inter-Agency Standing Committee (IASC)-led efforts. (OCHA, 2026-03-11)
• FTS tracks and publishes data on humanitarian funding flows. It presents this in a searchable, online database and also through two main lenses: total reported funding (everything reported to FTS by public and private donors, UN agencies UN funds, NGOs and others) humanitarian response plans and appeals (funding that is specifically reported or that can be specifically mapped against funding requirements stated in humanitarian response plans). (Financial Tracking Service, 2026-03-16)
• The Financial Tracking Service (FTS) is the central, continuously updated, fully downloadable public data source on global humanitarian funding flows. It brings together reporting from government donors, UN funds and agencies, NGOs and other humanitarian actors to provide a real-time picture of humanitarian funding across operations progress against response plans and appeals, including sector breakdowns and funding gaps. (Financial Tracking Service)
• FTS shows funding reported as Pledges, Commitments, and Paid Contributions (as defined by the reporting organization). Commitments and Paid contributions are counted in FTS totals (as they reflect signed agreements or completed transfers). (Financial Tracking Service)
• FTS supports humanitarian decision-making and advocacy by providing a real-time picture of humanitarian funding globally, both inside and outside coordinated response plans, and progress against response plans and appeals, including sector-level funding and gaps where available. (Financial Tracking Service, 2026-10-15)

• The Global Fund publishes grant disbursement data by country and disease on its Data Explorer platform at https://data.theglobalfund.org/, which includes visualizations and tables of disbursed amounts broken down by geography, grant cycle, and components such as HIV, Malaria, Tuberculosis, TB/HIV, RSSH, and Multicomponent. (The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2026-10-01)
• Global Fund disbursements are available on the Global Fund Data Explorer. (The Global Fund to Fight AIDS, Tuberculosis and Malaria)
• Downloadable data files and raw data related to grants, disbursements and more are available on the Data Service website at https://data-service.theglobalfund.org/. (The Global Fund to Fight AIDS, Tuberculosis and Malaria)

• Preferred data sources: Civil registration with complete coverage and medical certification of cause of death. (WHO)
• Data on maternal mortality and other relevant variables are obtained through databases maintained by WHO, UNICEF, the World Bank Group, and UNDESA/Population. (WHO)
• The preferred source of data is a civil registration system that records births and deaths on a continuous basis, collects information as events occur and covers the entire population. (UNICEF)
• The United Nations Inter-agency Group for Child Mortality Estimation (UN IGME) seeks to compile all available national-level data on child mortality, including data from vital registration systems, population censuses, household surveys and sample registration systems. (UNICEF)
• Preferred data sources: Civil registration with complete coverage. (WHO)
• For countries with adequate trend of data from civil registration, the calculations of under-five and infant mortality rates are derived from a standard period abridged life table. (WHO)